- Home
- BGM
as 12-18-2024 1:32pm EST
Stocks
BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.
| Founded: | 2019 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 50.6M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 46.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.10 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.77 - $11.67 | Next Earning Date: | 02-13-2025 |
| Revenue: | $29,870,461 | Revenue Growth: | -51.77% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest QILIAN INTERNATIONAL HLDG GROUP LTD News
BGM Breaking Stock News: Dive into BGM Ticker-Specific Updates for Smart Investing
PR Newswire
19 days ago
/C O R R E C T I O N -- BGM Group Ltd/
GlobeNewswire
19 days ago
AIX and BGM Group Forge Strategic Deal, Leading Healthcare, Pharma, and Insurance Industry Expansion with AI
TipRanks
20 days ago
Qilian International Announces Major Share Subscription Deal
PR Newswire
a month ago
BGM Group Welcomes Guilin Pharma for On-site Audit and Partnership Development
PR Newswire
2 months ago
Qilian International Holding Group Limited Announces Name Change to BGM Group Ltd.
Compare BGM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BGM QILIAN INTERNATIONAL HLDG GROUP LTD - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.